Advertisement
Advertisement

TRAW

TRAW logo

Traws Pharma, Inc. Common Stock

0.54
USD
Sponsored
+0.01
+1.50%
Aug 10, 15:59 UTC -4
Closed
exchange

After-Market

0.53

-0.01
-2.41%

Traws Pharma, Inc. Common Stock Profile

About

Traws Pharma Inc. is involved in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Traws Pharma Inc., formerly known as Onconova Therapeutics Inc., is based in NEWTOWN, Pa.

Info & Links

CEO

Iain Dukes

Headquarters

12 PENNS TRAIL
NEWTOWN, PA 18940, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

https://www.trawspharma.com

Auditor

KPMG LLP

Share holders

55

Employees

7

Traws Pharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

8.03M

Enterprise Value

4.89M

Enterprise Value/EBITDA(ttm)

-0.25

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.78

Price to Book(mrq)

--

Price to Cash(ytd)

0.70

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-5.72%

Return on Equity(ttm)

-913.18%

Return on Invested Capital(ttm)

1218.88%

Return on Assets(ttm)

-133.88%

Income Statement

Revenue(ttm)

2.73M

Revenue Per Share(ttm)

0.18

Gross Profit(ttm)

2.73M

EBITDA(ttm)3

-19.51M

Net Income Available to Common(ttm)

-13.91M

Diluted EPS(ttm)

-1.69

Share Statistics

Beta (5Y Monthly)

1.57

52-Week Change

-64.00%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

15.15M

Dividend Yield

0.00%

Float4

14.00M

% Held by Insiders

7.57%

% Held by Institutions

7.95%

Balance Sheet

Total Cash(mrq)

3.13M

Total Cash Per Share(mrq)

0.21

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.43%

Quick Ratio(mrq)

0.43%

Book Value Per Share(mrq)

-0.52

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.24

Free Cash Flow(ytd)

-2.58M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement